Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perineural Dexamethasone vs Dexmedetomidine as Adjuvants to Ropivacaine in iPACK and Adductor Canal Blocks for TKA
NCT07386600Completed
- Sponsor
- Poznan University of Medical Sciences
- Start
- Feb 2026
- Primary completion
- Sep 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexamethasone and dexmedetomidine in knee osteoarthritis (OA) (3 arms), sponsored by Poznan University of Medical Sciences. Primary endpoint: Cumulative opioid consumption in the first 24 hours after surgery. Started Feb 2026; status: completed.
02
Drugs
dexamethasonedexmedetomidine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT07386600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07386600.